SS Innovations International, Inc. (SSII)’s SSi Mantra System Sees 130% Installation Growth, Pioneers Cardiac Telesurgery

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. SS Innovations International, Inc. is one of them.

SS Innovations International, Inc. (NASDAQ:SSII) is advancing affordable surgical robotics with its flagship SSi Mantra system, offering a cost-efficient alternative to established platforms like Intuitive Surgical’s da Vinci. Approved in seven countries, including India, Indonesia, and the Philippines, the company is pursuing regulatory approval in the U.S. and Europe to expand its global footprint.

In September 2025, Naveen Kumar Amar was appointed Chief Financial Officer, bringing extensive international finance experience as SSII ramps up sales and prepares submissions for a U.S. FDA 510(k) application by October and CE mark certification in Europe in the first half of 2026.

SS Innovations International, Inc. (SSII)’s SSi Mantra System Sees 130% Installation Growth, Pioneers Cardiac Telesurgery

Financially, SS Innovations International, Inc. (NASDAQ:SSII) posted strong growth in Q2 2025, with revenue rising 121.8% to $10 million and gross profit more than tripling year-over-year. Installations of the SSi Mantra system surged 130% year-over-year, bringing the total installed base to 105 systems performing 4,657 surgeries as of June 30, 2025. Among its achievements, the firm performed the world’s first intercontinental robotic cardiac telesurgery in July 2025, highlighting its technological capabilities.

While we acknowledge the risk and potential of SSII as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SSII and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.